Oaktree Fund Advisors, LLC Alvotech Transaction History
Oaktree Fund Advisors, LLC
- $55.5 Million
- Q1 2025
A detailed history of Oaktree Fund Advisors, LLC transactions in Alvotech stock. As of the latest transaction made, Oaktree Fund Advisors, LLC holds 105,116 shares of ALVO stock, worth $889,281. This represents 1.83% of its overall portfolio holdings.
Number of Shares
105,116
Previous 116,294
9.61%
Holding current value
$889,281
Previous $1.54 Million
33.81%
% of portfolio
1.83%
Previous 3.1%
Shares
9 transactions
Others Institutions Holding ALVO
# of Institutions
48Shares Held
16MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.23MShares$35.8 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$22.9 Million20.4% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.87MShares$15.8 Million0.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.4MShares$11.9 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$11.2 Million6.46% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $2.1B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...